Karen Hunady | Director, Investor Relations and Corporate Communications |
Nancy Simonian | President, CEO & Director |
David Roth | Chief Medical Officer |
Jason Haas | CFO |
Philip Nadeau | TD Cowen |
Edward Tenthoff | Piper Sandler & Co. |
Jason Butler | JMP Securities |
Mark Breidenbach | Oppenheimer |
Good morning, and welcome to Syros Pharmaceuticals' First Quarter 2023 Financial Results Conference Call. [Operator Instructions]. This call is being webcast live on the Investors and Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded.
At this time, I would like to turn the call over to Karen Hunady, Director of Investor Relations and Corporate Communications at Syros.